Navigation Links
Dendreon Announces Plans to Seek Marketing Authorization for PROVENGE in Europe
Date:1/7/2011

d for transmissible infectious diseases.

The safety evaluation of PROVENGE was based on 601 prostate cancer patients in four randomized clinical trials who underwent at least one leukapheresis procedure. The most common adverse events (incidence greater than or equal to 15%) reported in patients in the PROVENGE group are chills, fatigue, fever, back pain, nausea, joint ache, and headache. Serious adverse events reported in patients in the PROVENGE group include acute infusion reactions (occurring within 1 day of infusion) and cerebrovascular events. In controlled clinical trials, severe (Grade 3) acute infusion reactions were reported in 3.5% of patients in the PROVENGE group. Reactions included chills, fever, fatigue, asthenia, dyspnea, hypoxia, bronchospasm, dizziness, headache, hypertension, muscle ache, nausea, and vomiting. No Grade 4 or 5 acute infusion reactions were reported in patients in the PROVENGE group.

To fulfill a post marketing requirement and as a part of the company's ongoing commitment to patients, Dendreon will conduct a registry of approximately 1,500 patients to further evaluate a small potential safety signal of cerebrovascular events. In four randomized clinical trials of PROVENGE in prostate cancer patients, cerebrovascular events were observed in 3.5% of patients in the PROVENGE group compared with 2.6% of patients in the control group.

For more information on PROVENGE, please see the full Prescribing Information at www.provenge.com or call Dendreon ON Call at 1-877-336-3736

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy (ACI) product candidates designed to
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
2. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
3. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
4. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
5. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
6. Dendreon Reports Third Quarter 2008 Financial Results
7. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
8. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
9. Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
10. Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
11. Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Hershey, PA & Rockville, MD (PRWEB) September 17, 2014 ... it won a Small Business Innovation Research (SBIR) grant ... allergy immunotherapy. The award will provide ITI with approximately ... , Tree nuts, a leading cause of food allergy, ... leading cause of anaphylaxis behind peanut allergy. Tree nut ...
(Date:9/17/2014)... 17, 2014 Terracon Corporation has announced ... TerraPure tank . This addition to the company’s ... FDA-compliant linear polyethylene and available in 125 or 250 ... ships in two weeks or less. , The new ... found in Terracon’s existing TerraPure tank line – plus ...
(Date:9/17/2014)... , Sept. 17, 2014 Intarcia Therapeutics, ... data from a study of the cost and predictability ... 50 th Annual Meeting of the European Association ... session today, Christian Frois , Ph.D., of Analysis ... series of planned Intarcia-sponsored, retrospective studies to characterize the ...
(Date:9/17/2014)... Hussey Copper , a leader in copper manufacturing ... Gilmour Academy Ice Arena,s conversion of more than 200 ... surface to help protect against bacteria.  MD-Cu 29 ... greater than 99.9% of MRSA, E-coli and other bacteria ... , Innovative Gilmour Academy prepares children ...
Breaking Biology Technology:Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 2Immunomic Therapeutics Awarded SBIR Grant to Develop Multi-Nut Allergy Immunotherapy 3Terracon Introduces Pre-Engineered TerraPure® Tank for Ultrapure Water Applications 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 2Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 3Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 4Intarcia Reveals New Insights At EASD Meeting Characterizing The Burden Of Poor Control And Non-Adherence To Anti-Diabetic Therapies 5Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 2Innovative Gilmour Academy Ice Arena changes more than 200 fixtures to Hussey Copper's MD-Cu29 antimicrobial copper to help protect against bacteria 3
... economy , ,Its a strategy, process and ... reaches across the entire spectrum of local, state, national, ... the life sciences and information technology. We can help ... in tourism, manufacturing, and agriculture to operate in real- ...
... , ,Spring of 99 was a great time to start ... WAVE Program (Weinert Applied Ventures in Entrepreneurship) at the ... and Neil Peters-Michauds Cascade Asset Management . As an ... , ,Our coursework included consulting projects for small technology-based businesses. ...
... Administration (FDA) recently began requiring applicants to pay significant ... medical devices and biologics. Such user fees have long ... required for applications related to devices and biologics. In ... review time, but at what cost? User fees impose ...
Cached Biology Technology:Real-Time Economy: Part 2 2Living in the Unreal World: A Survival Guide for Entrepreneurs 2Living in the Unreal World: A Survival Guide for Entrepreneurs 3Living in the Unreal World: A Survival Guide for Entrepreneurs 4Fast Track: FDA User Fees: Do Faster Review Times Justify the Financial Burden? 2
(Date:9/17/2014)... complex social behavior by studying nonhuman mammals and primates, ... With their unusually large brains relative to their body ... social environment---not merely in a large population of cooperating ... dynamic setting of alliances and competitors. The same is ... and social carnivores, like hyenas and lions. , A ...
(Date:9/17/2014)... MSSA could be curbed by coating hospital surfaces ... of shark skin, according to research published in ... Infection Control . , The study modelled how ... disease bacteria through touching, sneezes or spillages. The ... formulated to resemble shark skin. The study showed ...
(Date:9/16/2014)... at the Columbia Center for Children,s Environmental Health at ... to demonstrate an association between childhood asthma and prenatal ... of household products. Results appear online in the journal ... to mothers exposed during pregnancy to higher levels of ... had a 72 percent and 78 percent increase in ...
Breaking Biology News(10 mins):Being social: Learning from the behavior of birds 2Sharks' skin has teeth in the fight against hospital superbugs 2Phthalates heighten risk for childhood asthma 2Phthalates heighten risk for childhood asthma 3
... neuroscientists at the University of Wisconsin-Milwaukee (UWM) are working ... model the company has developed for researching diseases like ... are genetically altered rats, originally created by researchers at ... to clone genes related to human diseases. Called consomic ...
... of Mechanical and Aerospace Engineering Fred Dryer has a ... jet travel. With potentially major benefits for ... Dryer is advancing the fundamental knowledge of jet fuels ... to make alternative jet fuel sources feasible, they need ...
... light-emitting diodes, is intensifying the properties of LEDs by ... constantly think of tiny particles with a negative ... movement of these electrons that electric current flows and ... Steckl is one of the world,s leading experts in ...
Cached Biology News:A new kind of rat model 2Green skies: Engineer's work may reduce jet travel's role in global warming 2Green skies: Engineer's work may reduce jet travel's role in global warming 3Green skies: Engineer's work may reduce jet travel's role in global warming 4Salmon garnish points the way to green electronics 2Salmon garnish points the way to green electronics 3